Key preclinical findings included: Dose-dependent weight loss exceeding that of single- or dual-receptor agonists Improved glucose tolerance and insulin sensitivity Increased energy expenditure attributable to the glucagon receptor component Reduced hepatic steatosis Acceptable preclinical safety and toxicology profile These data supported an Investigational New Drug (IND) application to the FDA, enabling the transition to human clinical testing
33 A UK-based study in 493 school children aged 79 years found omega-3 fatty acid insufficiency was very common and associated with ADHD-related symptoms (eg, oppositional behavior and emotional instability)
The only definitive way is through analytical methods like HPLC-MS, which is not feasible for most labs
Vitamin C: This vitamin is your ultimate brightening ally
Laboratory monitoring, including hemoglobin A1c, should be performed quarterly if therapy has changed or glycemic targets are not being met, and twice yearly if stable at goal
However, repeatedly exposing it to temperature swings isn't ideal